EUVIMEDEUVIMED entdecken
Crossref

Size‐Tunable Boron Nanoreactors for Boron Neutron Capture Synergistic Chemodynamic Therapy of Tumor

Lin Li, Qian Zhao, Zhiqing Chen, Zican Zhao, Baojie Du, Mixue Wang, Peirong Bai, Xiaozhe Wang, Xiaofeng Ren, Liping Li iD, Ruiping Zhang

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202402307 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Lin Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, Ch…. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Boron Compounds, Quantum Dots, Boron. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Nature Science Foundation of China, Applied Basic Research Program of Shanxi Province, National Key R&D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Boron neutron capture therapy (BNCT) stands out as a noninvasive potential modality for invasive malignant tumors, with boron drugs playing a crucial role in its efficacy. Nevertheless, the development of boron drugs with biodegradability, as well as high permeability and retention effects, continues to present significant challenges. Here, we fabricate a size‐tunable boron nanoreactor (TBNR) via assembling boron nitride quantum dots (BNQDs) and Fe3+ for tumor BNCT and chemodynamic (CDT) synergistic treatment. The obtained TBNR with an appropriate size exhibits superior tumor accumulation and retention. Upon stimulation by the tumor microenvironment (TME), the contained Fe3+ undergo redox reactions with glutathione (GSH) to produce Fe2+ Fenton reagents, which in turn activate CDT function and simultaneously induce TBNR depolymerization. Subsequently, the released ultrasmall BNQDs exhibit intra‐deep penetration characteristic and are fully enriched at the tumor site. The in vivo experiments reveal that TBNR possesses excellent biocompatibility and superior synergistic anti‐tumor ability post neutron irradiation, resulting in significant shrinkage of subcutaneous 4T1 tumors. Moreover, the TBNR‐mediated BNCT has triggered an obvious immune response, which contributes to the long‐term suppression of tumors after neutron irradiation. To conclude, this study provides a new approach for constructing more efficient versatile nanocarriers for BNCT‐induced combination cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyBoron CompoundsQuantum DotsBoronNeoplasmsAnimalsMiceCell Line, TumorFemaleMice, Inbred BALB CTumor MicroenvironmentHumans

Stichwörter der Autor:innen

boron neutron capture therapychemodynamic therapysize‐tunable boron nanoreactortumor penetrationtumor retention

Substanzen

Boron Compoundsboron nitrideBoron

Autor:innen und Institutionen

  • Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
  • Academy of Medical Sciences, Shanxi Medical University, Taiyuan, 030001, China.
  • Department of Chemistry, Basic Medical College, Shanxi Medical University, Taiyuan, 030001, China.
  • Key Laboratory of Interface Science and Engineering in Advanced Materials, Ministry of Education, Taiyuan University of Technology, Taiyuan, 030024, China.
  • The Radiology Department of Shanxi Provincial People's Hospital, The Fifth Hospital of Shanxi Medical University, Taiyuan, 030012, China.

ORCID-Profile: Liping Li

Förderung

  • National Nature Science Foundation of China
  • Applied Basic Research Program of Shanxi Province
  • National Key R&D Program of China
  • Research project of Health Commission of Shanxi Province
  • Central Government Guided Local Science and Technology Development Fund Research Project
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Li, L., Zhao, Q., Chen, Z., Zhao, Z., Du, B., Wang, M., Bai, P., Wang, X., Ren, X., Li, L., & Zhang, R. (2025). Size‐Tunable Boron Nanoreactors for Boron Neutron Capture Synergistic Chemodynamic Therapy of Tumor. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402307

Vancouver

Li L, Zhao Q, Chen Z, Zhao Z, Du B, Wang M, et al. Size‐Tunable Boron Nanoreactors for Boron Neutron Capture Synergistic Chemodynamic Therapy of Tumor. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202402307

BibTeX
@article{Li2025,
  author = {Li, Lin and Zhao, Qian and Chen, Zhiqing and Zhao, Zican and Du, Baojie and Wang, Mixue and Bai, Peirong and Wang, Xiaozhe and Ren, Xiaofeng and Li, Liping and Zhang, Ruiping},
  title = {Size‐Tunable Boron Nanoreactors for Boron Neutron Capture Synergistic Chemodynamic Therapy of Tumor},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202402307}
}
Kostenlos starten →